Nanopore Sequencing in Ophthalmology

Launched by MEDICAL UNIVERSITY OF GRAZ · May 12, 2022

Keywords

ClinConnect Summary

This clinical trial, called "Nanopore Sequencing in Ophthalmology," is exploring a new way to quickly identify germs that cause endophthalmitis, a serious eye infection. Researchers are testing a device called the Oxford Nanopore MinION, which is a small and affordable tool that can analyze DNA and RNA. By using this device on samples taken during eye surgery, the study aims to see if it can accurately find the pathogens responsible for the infection, helping doctors make better treatment decisions.

To participate in this study, you need to be an adult with endophthalmitis, which means you have this eye infection. Unfortunately, if you cannot provide consent to participate or are involved in other clinical studies, you won't be eligible. If you join the trial, you'll help researchers understand how effective this new method is, which could lead to improved care for patients with eye infections in the future. The study is currently looking for participants, so if you're interested, it's a good idea to talk to your doctor.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Eyes of patients with endophthalmitis
• Exclusion Criteria:
• • No informed consent possible
• • Participation in other studies